Halmos B - Search Results

1

The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy.

Sharma J, Shum E, Chau V, Paucar D, Cheng H, Halmos B. Sharma J, et al. Among authors: halmos b. Respiration. 2017;93(1):1-14. doi: 10.1159/000453086. Epub 2016 Nov 29. Respiration. 2017. PMID: 27894113 Review. No abstract available.

2

Molecular testing in lung cancer: the time is now.

Cheng H, Xu X, Costa DB, Powell CA, Halmos B. Cheng H, et al. Among authors: halmos b. Curr Oncol Rep. 2010 Sep;12(5):335-48. doi: 10.1007/s11912-010-0118-z. Curr Oncol Rep. 2010. PMID: 20623207 Review.

3

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.

Shu C, Cheng H, Wang A, Mansukhani MM, Powell CA, Halmos B, Borczuk AC. Shu C, et al. Among authors: halmos b. Mod Pathol. 2013 Feb;26(2):239-46. doi: 10.1038/modpathol.2012.158. Epub 2012 Sep 21. Mod Pathol. 2013. PMID: 22996376 Free article.

4

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Lieberman HB, Halmos B. Cheng H, et al. Among authors: halmos b. Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28. Carcinogenesis. 2013. PMID: 23275151 Free PMC article.

5

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.

Liu X, Jia Y, Stoopler MB, Shen Y, Cheng H, Chen J, Mansukhani M, Koul S, Halmos B, Borczuk AC. Liu X, et al. Among authors: halmos b. J Clin Oncol. 2016 Mar 10;34(8):794-802. doi: 10.1200/JCO.2015.62.0674. Epub 2015 Jul 27. J Clin Oncol. 2016. PMID: 26215952

6

RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.

Cheng H, Zou Y, Ross JS, Wang K, Liu X, Halmos B, Ali SM, Liu H, Verma A, Montagna C, Chachoua A, Goel S, Schwartz EL, Zhu C, Shan J, Yu Y, Gritsman K, Yelensky R, Lipson D, Otto G, Hawryluk M, Stephens PJ, Miller VA, Piperdi B, Perez-Soler R. Cheng H, et al. Among authors: halmos b. Cancer Discov. 2015 Dec;5(12):1262-70. doi: 10.1158/2159-8290.CD-14-0971. Epub 2015 Sep 14. Cancer Discov. 2015. PMID: 26370156 Free PMC article.

7

Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.

Cheng H, Zhang Z, Rodriguez-Barrueco R, Borczuk A, Liu H, Yu J, Silva JM, Cheng SK, Perez-Soler R, Halmos B. Cheng H, et al. Among authors: halmos b. Oncotarget. 2016 May 17;7(20):28976-88. doi: 10.18632/oncotarget.6721. Oncotarget. 2016. PMID: 26716514 Free PMC article.

8

Recent advances in the management of pulmonary sarcomatoid carcinoma.

Shum E, Stuart M, Borczuk A, Wang F, Cheng H, Halmos B. Shum E, et al. Among authors: halmos b. Expert Rev Respir Med. 2016 Apr;10(4):407-416. doi: 10.1586/17476348.2016.1157475. Epub 2016 Mar 10. Expert Rev Respir Med. 2016. PMID: 26962707

9

Has MET met its match?

Borczuk A, Paucar D, Halmos B. Borczuk A, et al. Among authors: halmos b. Ann Transl Med. 2016 Mar;4(5):97. doi: 10.21037/atm.2016.01.15. Ann Transl Med. 2016. PMID: 27047956 Free PMC article. No abstract available.

10

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.

Cheng H, Janakiram M, Borczuk A, Lin J, Qiu W, Liu H, Chinai JM, Halmos B, Perez-Soler R, Zang X. Cheng H, et al. Among authors: halmos b. Clin Cancer Res. 2017 Feb 1;23(3):825-832. doi: 10.1158/1078-0432.CCR-15-3071. Epub 2016 Aug 23. Clin Cancer Res. 2017. PMID: 27553831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters